Morolimumab

Morolimumab is a human monoclonal antibody against the human Rhesus factor.[1][2]

Morolimumab
Monoclonal antibody
TypeWhole antibody
SourceHuman
TargetRhD
Clinical data
ATC code
  • none
Identifiers
CAS Number
ChemSpider
  • none
UNII
 ☒NcheckY (what is this?)  (verify)

References
  1. "Proposed International Nonproprietary Names: Morolimumab" (PDF). WHO Drug Information. Geneva: World Health Organization. 13 (1): 45. 1991.
  2. Pelletier JP, Mukhtar F (2020). "Chapter 16 - Passive Monoclonal and Polyclonal Antibody Therapies". In Maitta RW (ed.). Immunologic Concepts in Transfusion Medicine. Philadelphia: Elsevier. p. 300. doi:10.1016/B978-0-323-67509-3.00016-0. ISBN 978-0-323-67510-9. S2CID 213508934.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.